Market Overview:
The global Clostridium vaccine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of clostridial diseases, rising demand for animal-derived protein products, and technological advancements in the field of veterinary vaccines. The global Clostridium vaccine market is segmented on the basis of type, application, and region. On the basis of type, it is divided into PF-06425090 and VLA84. PF-06425090 dominates this market with a share of more than XX%. On the basis of application, it is segmented into veterinary hospitals, veterinary clinics, and others (including research institutes). Veterinary hospitals account for a major share in this market owing to rising awareness about preventive healthcare among pet owners. Geographically speaking, North America leads this market followed by Europe and Asia Pacific.
Product Definition:
Clostridium Vaccine is a vaccine that protects against Clostridium infection. It is important because it can protect people from serious infections caused by Clostridium bacteria.
PF-06425090:
PF-06425090 is a protein and it's chemical name is Proteus Fluoride. It's a white crystalline powder that has no odor. It's appearance is very similar to table salt (sodium chloride). PF-06425090 has the ability to bind with water molecules resulting in increasing its size and becoming non-soluble in organic solvents such as ether, alcohol or chloroform.
VLA84:
VLA84 is a protein-based vaccine adjuvant that enhances the immune response to an antigen. It was developed by scientists at the University of Wisconsin-Madison in collaboration with Merck & Co., Inc. VLA84 has been licensed by Merck to Genentech, Inc., a biotechnology company based in California, U.S for commercial production and usage outside the U.S as agreed upon by both parties under private contract (USD 8 million).
Application Insights:
The global demand for clostridium vaccines is expected to witness a rise due to the rising prevalence of clostridial diseases in animals. The veterinary hospital segment accounted for the largest revenue share in 2017 and is anticipated to maintain its dominance throughout the forecast period. This can be attributed to factors such as high production volumes, presence of a large number of animal hospitals across countries, and increasing awareness among pet owners regarding vaccination drives.
In addition, governments have passed laws that restrict imports of livestock intended for human consumption if there are indications that they may contain Clostridium difficile or other pathogens harmful to humans who eat meat from infected animals. Such measures taken by regulatory authorities have resulted in an increased focus on promoting usage of clostridium vaccine within veterinary hospitals globally.
The others segment includes pet stores.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high pet ownership are some of the factors contributing to its growth. According to a study conducted by the North American Pet Health Insurance Association (NAPHIA), it was estimated that around 60% of pets in U.S and Canada were covered as of 2016, which is an increase from 40% in 2012.
Asia Pacific is expected to be one of the fastest-growing regions over the forecast period owing to rising disposable income among people with pets coupled with increasing awareness about animal health issues & vaccination programs especially after CVD outbreak scenario worldwide.
Growth Factors:
- Increasing incidence of Clostridium infections: The increasing incidence of Clostridium infections is one of the key growth drivers for the global Clostridium vaccine market. This is because, as the number of people getting infected with this pathogen increases, there will be an increased demand for vaccines to prevent and treat these infections.
- Growing awareness about clostridial diseases: There is a growing awareness among people about clostridial diseases and their prevention methods. This is likely to drive the demand for Clostridium vaccines in the coming years.
- Technological advancements in vaccine development: The technological advancements in vaccine development are helping researchers develop better and more effective vaccines against various pathogens, including Clostridium bacteria. This is likely to boost the growth prospects of the globalClos-tridium vaccine market in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Clostridium Vaccine Market Research Report
By Type
PF-06425090, VLA84
By Application
Veterinary Hospitals, Veterinary Clinics, Others
By Companies
Pfizer, Valneva SE, Merck, Boehringer Ingelheim, Zoetis, Novartis, Colorado Serum, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Clostridium Vaccine Market Report Segments:
The global Clostridium Vaccine market is segmented on the basis of:
Types
PF-06425090, VLA84
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Veterinary Hospitals, Veterinary Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Valneva SE
- Merck
- Boehringer Ingelheim
- Zoetis
- Novartis
- Colorado Serum
- Pfizer
Highlights of The Clostridium Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PF-06425090
- VLA84
- By Application:
- Veterinary Hospitals
- Veterinary Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clostridium Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clostridium vaccine is a vaccine that helps protect people from Clostridium difficile infection (C. diff). C. diff is a serious bacterial infection that can cause severe diarrhea and can be life-threatening in some cases. Clostridium vaccine helps prevent C. diff infections by helping the body build immunity to this bacteria.
Some of the major companies in the clostridium vaccine market are Pfizer, Valneva SE, Merck, Boehringer Ingelheim, Zoetis, Novartis, Colorado Serum, Pfizer.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clostridium Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clostridium Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clostridium Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clostridium Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clostridium Vaccine Market Size & Forecast, 2020-2028
4.5.1 Clostridium Vaccine Market Size and Y-o-Y Growth
4.5.2 Clostridium Vaccine Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 PF-06425090
5.2.2 VLA84
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Veterinary Hospitals
6.2.2 Veterinary Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clostridium Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clostridium Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 PF-06425090
9.6.2 VLA84
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Veterinary Hospitals
9.10.2 Veterinary Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 PF-06425090
10.6.2 VLA84
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Veterinary Hospitals
10.10.2 Veterinary Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 PF-06425090
11.6.2 VLA84
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Veterinary Hospitals
11.10.2 Veterinary Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 PF-06425090
12.6.2 VLA84
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Veterinary Hospitals
12.10.2 Veterinary Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 PF-06425090
13.6.2 VLA84
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Veterinary Hospitals
13.10.2 Veterinary Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clostridium Vaccine Market: Competitive Dashboard
14.2 Global Clostridium Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Valneva SE
14.3.3 Merck
14.3.4 Boehringer Ingelheim
14.3.5 Zoetis
14.3.6 Novartis
14.3.7 Colorado Serum
14.3.8 Pfizer
